Indeed, the DPP4 inhibitor vildagliptin has been demonstrated to suppress lung metastasis of colorectal cancer via reduced autophagy, increased apoptosis, and inhibition of the cell cycle regulator phospho-CDC2 (pCDC2) in a syngeneic mouse model [65]. The gene discussed is DPP4; the disease is colorectal cancer.